These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 25087952)
1. Hyper-O-GlcNAcylation inhibits the induction of heat shock protein 70 (Hsp 70) by sodium arsenite in HeLa cells. Miura Y; Sato T; Sakurai Y; Sakai R; Hiraoka W; Endo T Biol Pharm Bull; 2014; 37(8):1308-14. PubMed ID: 25087952 [TBL] [Abstract][Full Text] [Related]
2. Implications of the O-GlcNAc modification in the regulation of nuclear apoptosis in T cells. Johnson B; Opimba M; Bernier J Biochim Biophys Acta; 2014 Jan; 1840(1):191-8. PubMed ID: 24035784 [TBL] [Abstract][Full Text] [Related]
3. Role of the O-GlcNAc modification on insulin resistance and endoplasmic reticulum stress in 3T3-L1 cells. Sermikli BP; Aydogdu G; Yilmaz E Mol Biol Rep; 2020 Aug; 47(8):5927-5942. PubMed ID: 32691273 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy. Yokoe S; Asahi M; Takeda T; Otsu K; Taniguchi N; Miyoshi E; Suzuki K Glycobiology; 2010 Oct; 20(10):1217-26. PubMed ID: 20484118 [TBL] [Abstract][Full Text] [Related]
5. Glucosamine modulates TNF-α-induced ICAM-1 expression and function through O-linked and N-linked glycosylation in human retinal pigment epithelial cells. Chen CL; Liang CM; Chen YH; Tai MC; Lu DW; Chen JT Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2281-91. PubMed ID: 22427561 [TBL] [Abstract][Full Text] [Related]
6. Glucosamine regulates hepatic lipid accumulation by sensing glucose levels or feeding states of normal and excess. Park J; Lee Y; Jung EH; Kim SM; Cho H; Han IO Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Oct; 1865(10):158764. PubMed ID: 32663610 [TBL] [Abstract][Full Text] [Related]
7. O-GlcNAcylation promotes non-amyloidogenic processing of amyloid-β protein precursor via inhibition of endocytosis from the plasma membrane. Chun YS; Park Y; Oh HG; Kim TW; Yang HO; Park MK; Chung S J Alzheimers Dis; 2015; 44(1):261-75. PubMed ID: 25208619 [TBL] [Abstract][Full Text] [Related]
8. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins. Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293 [TBL] [Abstract][Full Text] [Related]
9. O-GlcNAcylation-inducing treatments inhibit estrogen receptor α expression and confer resistance to 4-OH-tamoxifen in human breast cancer-derived MCF-7 cells. Kanwal S; Fardini Y; Pagesy P; N'tumba-Byn T; Pierre-Eugène C; Masson E; Hampe C; Issad T PLoS One; 2013; 8(7):e69150. PubMed ID: 23935944 [TBL] [Abstract][Full Text] [Related]
10. O-GlcNAc modification affects the ATM-mediated DNA damage response. Miura Y; Sakurai Y; Endo T Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405 [TBL] [Abstract][Full Text] [Related]
11. Identification of differentially expressed proteins by treatment with PUGNAc in 3T3-L1 adipocytes through analysis of ATP-binding proteome. Lee JE; Park JH; Moon PG; Baek MC Proteomics; 2013 Oct; 13(20):2998-3012. PubMed ID: 23946262 [TBL] [Abstract][Full Text] [Related]
12. The synthesis and biological evaluation of some carbocyclic analogues of PUGNAc. Scaffidi A; Stubbs KA; Vocadlo DJ; Stick RV Carbohydr Res; 2008 Nov; 343(16):2744-53. PubMed ID: 18804755 [TBL] [Abstract][Full Text] [Related]
13. Selective decrease of membrane-associated PKC-alpha and PKC-epsilon in response to elevated intracellular O-GlcNAc levels in transformed human glial cells. Matthews JA; Acevedo-Duncan M; Potter RL Biochim Biophys Acta; 2005 Apr; 1743(3):305-15. PubMed ID: 15843043 [TBL] [Abstract][Full Text] [Related]
14. OGT-mediated O-GlcNAcylation promotes NF-κB activation and inflammation in acute pancreatitis. Zhang D; Cai Y; Chen M; Gao L; Shen Y; Huang Z Inflamm Res; 2015 Dec; 64(12):943-52. PubMed ID: 26407569 [TBL] [Abstract][Full Text] [Related]
15. Dynamic regulation and involvement of the heat shock transcriptional response in arsenic carcinogenesis. Khalil S; Luciano J; Chen W; Liu AY J Cell Physiol; 2006 May; 207(2):562-9. PubMed ID: 16447264 [TBL] [Abstract][Full Text] [Related]
16. Increased protein O-GlcNAc modification inhibits inflammatory and neointimal responses to acute endoluminal arterial injury. Xing D; Feng W; Nöt LG; Miller AP; Zhang Y; Chen YF; Majid-Hassan E; Chatham JC; Oparil S Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H335-42. PubMed ID: 18469144 [TBL] [Abstract][Full Text] [Related]
17. O-GlcNAcylation involvement in high glucose-induced cardiac hypertrophy via ERK1/2 and cyclin D2. Ding F; Yu L; Wang M; Xu S; Xia Q; Fu G Amino Acids; 2013 Aug; 45(2):339-49. PubMed ID: 23665912 [TBL] [Abstract][Full Text] [Related]
18. Glucosamine-induced increase in Akt phosphorylation corresponds to increased endoplasmic reticulum stress in astroglial cells. Matthews JA; Belof JL; Acevedo-Duncan M; Potter RL Mol Cell Biochem; 2007 Apr; 298(1-2):109-23. PubMed ID: 17136481 [TBL] [Abstract][Full Text] [Related]
19. Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate. Haltiwanger RS; Grove K; Philipsberg GA J Biol Chem; 1998 Feb; 273(6):3611-7. PubMed ID: 9452489 [TBL] [Abstract][Full Text] [Related]